The customer is a latin-american pharmaceutical manufacturer that manufactures, among other things, insulin and insulin analogues. This delivery refers to silica for the production of insulin. The delivery is made against a recent order with an order value of about TSEK 300.
 
”We have for some time collaborated with this customer on the purification of one of their diabetes drugs where we at the end of last year conducted method development, after which they initiated evaluation of our silica. Now that we have a product from our large-scale plant that we are satisfied with, we supply silica so that they can include it in their production”, Katarina Alenäs, Senior Vice President Chromatography at Nanologica comments.

Several customers have successfully evaluated Nanologica's silica for preparative chromatography, NLAB Saga®, in different stages. Last year, the company took multiple orders for large-scale evaluation.
 
”The orders we have taken so far consist of several different product types at different volumes. The first delivery that is now dispatched is one type of product, but we will gradually deliver other product types in demanded volumes. I remain very optimistic about our opportunities to gradually establish ourselves as a supplier of high-quality silica for purification of peptides and it is very gratifying that our silica is included in a customer's production for the first time”, Nanologica’s CEO Andreas Bhagwani continues.